tiprankstipranks

Mark Parrish Insider Profile

4 Followers
Mark Parrish, Director at Omnicell, holds 121.42K shares in Viatris (Ticker: VTRS), holds 64.28K shares in Omnicell (Ticker: OMCL), holds 70.67K shares in Cardinal Health (Ticker: CAH).
tipranks
Mark Parrish

Mark Parrish
Omnicell (OMCL)
Director

Ranked #92,423 out of 98,624 Corporate Insiders

Profitable Transactions

9%
1 out of 11 Profitable Transactions

Average Return

-32.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
69.55%
16.83%
13.60%
0.02%
A breakdown of Mark Parrish's holdings

Insider Roles

Cardinal Health
(CAH)
CEO - HSCS
Omnicell
(OMCL)
Director
Viatris
(VTRS)
Director
Bausch Health Companies
(BHC)
Director
Roles that Mark Parrish holds in companies

Most Profitable Insider Trade

Stock:
Viatris
(VTRS)
Rating:Informative Sell
Date:Feb 03, 2015 - Feb 03, 2016
Return:+4.20%
The most profitable trade made by Mark Parrish

Mark Parrish's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Omnicell
Aug 14, 2023
Director
Uninformative Buy
$1.75M
Viatris
Mar 05, 2024
Director
Uninformative Buy
$1.41M
Cardinal Health
CEO - HSCS
$7.22M
Bausch Health Companies
Jan 04, 2010
Director
Uninformative Buy
$1.75K
List of latest transactions for each holding click on a transaction to see Mark Parrish's performance on stock

Mark Parrish insider profile FAQ

What is the percentage of profitable transactions made by Mark Parrish?
The percentage of profitable transactions made by Mark Parrish is 9%.
    What is the average return per transaction made by Mark Parrish?
    The average return per transaction made by Mark Parrish is -32.10%.
      What stocks does Mark Parrish hold?
      Mark Parrish holds: OMCL, VTRS, CAH, BHC stocks.
        What was Mark Parrish’s latest transaction?
        Mark Parrish latest transaction was an Uninformative Buy of ―.
          What was Mark Parrish's most profitable transaction?
          Mark Parrish’s most profitable transaction was an Informative Sell of VTRS stock on February 3, 2015. The return on the trade was 4.20%.
            What is Mark Parrish's role in Omnicell?
            Mark Parrish's role in Omnicell is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.